New Alzheimer’s Drug Slows Cognitive Decline in Early Test

webmd logo fb

March 15, 2021 — An experimental drug appeared to slow cognitive decline in people with early Alzheimer’s disease, according to newly published research. The drug, donanemab, is an antibody that targets and removes plaques from the brain called amyloid-beta, which are thought to play a role in Alzheimer’s disease. Compared to people in the study … Read more

Nasal Spray Vaccine for COVID-19 in Early Trials

TUESDAY, Jan. 19, 2021 (HealthDay News) — A spritz instead of a shot to ward off COVID-19? Researchers report that a nasal spray vaccine against the new coronavirus shows promise in animal testing. Rodents that were given two doses of the vaccine had antibody and T-cell responses that were strong enough to suppress SARS-CoV-2, … Read more

Calorie Count: Eating Early Won’t Boost Weight Loss

By Steven Reinberg HealthDay Reporter TUESDAY, Nov. 10, 2020 (HealthDay News) — If you’re overweight, eating most of your calories early in the day won’t boost the benefit of a healthy diet, new research suggests. In a 12-week study, 41 people ate the same healthy diet, but one group ate 80% of … Read more

Early Skin-to-Skin Contact Helps Baby’s Brain

webmd logo fb

Instinctively we’ve always known it: There’s something special about a mother’s touch. Research suggests that skin-to-skin contact in the first few months of life can play a key role in baby’s development, influencing brain activity and stress hormones at a critical time. “Our brains are not fully developed when we’re born, especially the … Read more

Chinese COVID Vaccine Shows Promise in Early Trial

By Robert Preidt HealthDay Reporter FRIDAY, Oct. 16, 2020 (HealthDay News) — An experimental COVID-19 vaccine appeared to be safe and triggered an immune response in healthy people, according to preliminary results of a small, early-stage clinical trial. The study of the vaccine based on inactivated whole SARS-CoV-2 virus (BBIBP-CorV) included … Read more